SC 13D/A

AMENDMENT NO. 1 TO THE SCHEDULE 13D

Company: Sensei Biotherapeutics, Inc.
Filed: November 2, 2022
Accession Number: 0000921895-22-002887

View Document ↗ View on SEC.gov ↗